VAERS reports by lot

GSK Varicella/Shingles lot 3Z4KL: VAERS reports

142 VAERS reports list lot 3Z4KL as a GSK Varicella/Shingles vaccine, received between 2018-01-03 and 2020-07-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
142
Reports
6%
Marked serious
1
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction17932%
General / Systemic (non-local)13424%
Dermatological (non-injection-site)539%
Neurological509%
Musculoskeletal509%
Cardiac / Cardiovascular336%
Allergic / Anaphylactic285%
Gastrointestinal265%
Psychiatric / Neuropsychiatric61%
Respiratory51%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California15
New York9
Pennsylvania9
Florida7
Minnesota7
Michigan5
Illinois5
Arizona5
Missouri5
New Jersey4
Ohio4
Washington3

Reports by month received

2018-0114
2018-0225
2018-0346
2018-0425
2018-0513
2018-064
2018-074
2018-084
2018-094
2018-111
2020-011
2020-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.